Navigation Links
Tetra Discovery Partners Receives Major NIH Award To Develop New Alzheimer's Drug
Date:6/19/2012

GRAND RAPIDS, Mich., June 19, 2012 /PRNewswire/ -- Tetra Discovery Partners LLC, a leader in the design of new treatments for major neurological conditions based on PDE4 modulation in the brain, today announced it has been awarded a five-year cooperative agreement by the National Institutes of Health (NIH).  The award will support Tetra's efforts to develop a new drug to treat mild cognitive impairment, which is typically associated with aging and often precedes and accompanies Alzheimer's disease.

Tetra's award includes up to $1.5 million in direct funding and access to millions of additional dollars worth of contracted research services; the Company estimates that the total value of the NIH award to be worth at least $10 million over the project's anticipated five-year period.  The award was made through the Blueprint Neurotherapeutics Network (BPN), a recently launched NIH initiative involving the National Institute of Neurological Disorders and Stroke and the National Institute of Aging.  Under the terms of its cooperative agreement with NIH, Tetra will retain the intellectual property related to its research and be responsible for the commercialization of the new drug.

"We are delighted that Tetra Discovery Partners has been accepted into NIH's highly selective Blueprint Neurotherapeutics Network," said Mark Gurney, Ph.D., Tetra's founder and president.  "We expect that the funding and access to industry resources provided by the BPN will help support the significant acceleration of Tetra's work, which holds real promise for the millions of individuals and families contending with age-related cognitive decline and the ravages of Alzheimer's."

Tetra's research focuses on designing drugs that inhibit phosphodiesterase 4 (PDE4), a key enzyme in the brain that controls the biochemical process of memory.  The compounds designed by Tetra act like a type of molecular glue, closing a "lid" over the PDE4 catalytic si
'/>"/>

SOURCE Tetra Discovery Partners LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AMRI Further Expands Discovery Capabilities in India
2. Drug Discovery Technologies Market Soars to $79 billion by 2017, Driven by Innovations in Pipeline and Tools Development
3. Aethlon Medical (AEMD) Note: Cancer Research Discovery - Melanoma Exosomes Fuel Organ Metastasis
4. Dr. Paul Karila Appointed Head of Discovery Services at Cellectricon AB
5. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
6. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
7. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
8. TeraDiscoveries to Use its Inverse Design Software Running on Windows Azure to Advance Its Computational Drug Discovery Process
9. CarePoint Partners Expands Coverage in Southeast
10. Medifast Announces International Expansion Into Mexico Through Strategic Partnership with Medix
11. UBM Canon, the Global MedTech Authority, Partners with the World Medical Device Organization, WMDO, to Provide Medical Device Companies with Industry-Related Online Training Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 30, 2014 Electronic prescribing or ... of prescription related information between prescriber, dispenser ... a physician and nurse practitioner to transmit ... error occurs during pharmacy operations. E-Prescribing system ... provides complete medical lists, conducts all security ...
(Date:10/31/2014)... Oct. 31, 2014  AbbVie (NYSE: ... third quarter ended Sept. 30, 2014. ... of our business with double-digit growth from HUMIRA ... grew nearly 14 percent in the quarter excluding ... executive officer, AbbVie.  "We exceeded our outlook for ...
(Date:10/30/2014)... MAHWAH, N.J. , Oct. 30, 2014 ... PGA TOUR and Champions Tour, is rounding out its ... Cup Championship in Scottsdale, AZ. ... PGA TOUR and Champions Tour that the brand has ... destination designed to educate golf fans on the importance ...
Breaking Medicine Technology:E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2AbbVie Reports Third-Quarter 2014 Financial Results 2AbbVie Reports Third-Quarter 2014 Financial Results 3AbbVie Reports Third-Quarter 2014 Financial Results 4AbbVie Reports Third-Quarter 2014 Financial Results 5AbbVie Reports Third-Quarter 2014 Financial Results 6AbbVie Reports Third-Quarter 2014 Financial Results 7AbbVie Reports Third-Quarter 2014 Financial Results 8AbbVie Reports Third-Quarter 2014 Financial Results 9AbbVie Reports Third-Quarter 2014 Financial Results 10AbbVie Reports Third-Quarter 2014 Financial Results 11AbbVie Reports Third-Quarter 2014 Financial Results 12AbbVie Reports Third-Quarter 2014 Financial Results 13AbbVie Reports Third-Quarter 2014 Financial Results 14AbbVie Reports Third-Quarter 2014 Financial Results 15AbbVie Reports Third-Quarter 2014 Financial Results 16AbbVie Reports Third-Quarter 2014 Financial Results 17AbbVie Reports Third-Quarter 2014 Financial Results 18AbbVie Reports Third-Quarter 2014 Financial Results 19AbbVie Reports Third-Quarter 2014 Financial Results 20AbbVie Reports Third-Quarter 2014 Financial Results 21AbbVie Reports Third-Quarter 2014 Financial Results 22AbbVie Reports Third-Quarter 2014 Financial Results 23AbbVie Reports Third-Quarter 2014 Financial Results 24Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 2Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 3Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 4
... Show Increased Enzyme Levels in Two Most ... /PRNewswire/ -- Amicus,Therapeutics, a biopharmaceutical company developing ... a range of human genetic diseases, announced ... preclinical studies of,Plicera(TM) (isofagomine tartrate, AT2101) for ...
... the Targeted,Anticancer Therapies (TAT 2007) and the ... Phase 1 Trial Design, SOUTH SAN FRANCISCO, ... Inc. , presented,non-clinical data on its development-stage ... on targeted anticancer,medicines. Findings from in vitro ...
Cached Medicine Technology:Amicus Therapeutics Presents Preclinical Data from Studies of,Plicera for Gaucher Disease 2Amicus Therapeutics Presents Preclinical Data from Studies of,Plicera for Gaucher Disease 3Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 2Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 3
(Date:10/31/2014)... 2014 — A team from the Broad Institute, ... of California, Santa Cruz, was awarded one of ... Pilot contracts with the goal of building a ... Cancer Genome Atlas (TCGA) and other datasets by ... in one cloud environment. This co-location will enable ...
(Date:10/31/2014)... At the start of 2014, numerous news ... monoxide poisoning in their homes. Now, as 2015 (and ... Missouri-based heating and cooling company is taking a more ... the home heating season with the assurance that their ... Nov. 1, 2014, E and Q Heating and Cooling ...
(Date:10/31/2014)... apnea may make it hard for you to remember simple ... your house keys, a small study suggests. Tests on ... -- called spatial memory -- was impaired when sleep apnea ... of sleep weren,t affected. REM sleep is the deepest level ... for the first time that sleep apnea, an increasingly common ...
(Date:10/31/2014)... lab device to give cancer researchers an unprecedented microscopic ... spread through the body, causing more than 90 percent ... tumor cells travel, the device could uncover new ways ... the university,s Whiting School of Engineering and its Institute ... new system recently in the journal Cancer Research ...
(Date:10/31/2014)... scientists have found a drug combination that can trigger ... the way for new treatments, according to research that ... (NCRI) Cancer Conference in Liverpool next week*. , When ... chain of events culminating in self destruction. But cancer ... immortal. This means that cells grow out of control ...
Breaking Medicine News(10 mins):Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 2Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 3Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:Sleep Apnea May Steal Some of Your Memory: Study 2Health News:Viewing cancer on the move: New device yields close-up look at metastasis 2Health News:Viewing cancer on the move: New device yields close-up look at metastasis 3Health News:Scientists trigger self-destruct switch in lung cancer cells 2
... America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood ... ) focused on bringing the life saving potential of ... announce that between February 15, 2009, and today, it has ... percent. This follows the announcement on Feb. 12, 2009 ...
... Stars Perform to Raise Awareness of Neurological DiseaseEAST RUTHERFORD, N.J., April ... Foundation: WHO: Anthony Galde of Wicke ... Research Foundation WHAT: Curtain Call for a Caus ... & the Dystonia Medical Research Foundation host the 2nd Annual ...
... The United States Marine Corps launches its inaugural ... city opens its doors to the nearly 2,000 Marines ... Chicagoland area. "Established to recognize the contributions of ... which they came, Marine Week also showcases the rich ...
... arthritis (RA) is a systemic disease or an autoimmune disorder ... the thin layer of cells called the synovium that lines ... are swollen joints and crippling stiffness, particularly of the hands ... and also impedes mobility and quality of life. RA cannot ...
... vaccines and critical-care biopharmaceuticals announces exclusive sanofi pasteur Fluzone® agreement for ... ... (Vocus) April 6, 2009 -- As a trusted partner ... is pleased to announce that sanofi pasteur has named FFF the ...
... Lens Boot Camp™ - a first-of-its-kind training program to help refractive ... that its first boot camp session will be held on June ... ... Camarillo, CA (PRWEB) April 6, 2009 -- Premium Lens Boot Camp™ ...
Cached Medicine News:Health News:Cord Blood Announces $1.75 Million Reduction in Long Term Debt 2Health News:Broadway Comes to New Jersey 2Health News:Marine Corps Launches Inaugural Marine Week in Chicago, May 11-17 2Health News:Marine Corps Launches Inaugural Marine Week in Chicago, May 11-17 3Health News:Rheumatoid Arthritis Therapeutics in Thailand 2Health News:Rheumatoid Arthritis Therapeutics in Thailand 3Health News:FFF Named the Exclusive Distributor of Fluzone for GPOs & Announces New Fluzone Return Policy 2Health News:Premium Lens Boot Camp™ Helps Refractive Surgeons Grow Their Premium IOL Practice 2
Cordis DUCOR Catheters are available in a broad variety of French sizes and configurations. These catheters combine an atraumatic tip with either a braided or non-braided body....
The advanced center-of-the-arc system allows an infinite choice of trajectories. The system's lightweight durable frame provides accuracy, simplicity, patient mobility and accessibility....
The CRW system epitomizes simplicity, quality assurance, and versatility....
Used for complex diagnostic and interventional procedures....
Medicine Products: